The Medicines and Healthcare products Regulatory Agency (MHRA) has today 1 May 2026, approved Linerixibat (Lynavoy) for use to treat an itch in adults…
NPA calls for compensation for pharmacies over sertraline recall Chemist+DruggistPrecautionary recall of antidepressant medication due to manufacturing error GOV.UKAntidepressant recalled…